Self-Monitoring Using Mobile App for Reduction of Rehospitalization and Mortality in Heart Failure (SMART-HF)

Seoul National University Bundang Hospital7 sites in 1 country84 target enrollmentOctober 19, 2022

ConditionsHeart Failure

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Heart Failure
Sponsor: Seoul National University Bundang Hospital
Enrollment: 84
Locations: 7
Primary Endpoint: HF symptom by questionnaire
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The investigators developed a mobile health platform to self-management in HF. The aim of this study is to evaluate whether this smartphone app-based intervention can improve symptoms of HF when compared to usual care in HF patients.

Registry

clinicaltrials.gov

Start Date

October 19, 2022

End Date

January 26, 2023

Last Updated

2 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Seoul National University Bundang Hospital

Responsible Party

Principal Investigator

Dong-Ju Choi

Professor

Seoul National University Bundang Hospital

Eligibility Criteria

Inclusion Criteria

•Patients aged 20 years or older hospitalized for acute heart failure.
•Patients who have obvious symptoms or sign of HF at admission
•N-terminal prohormone of brain natriuretic peptide (NT-proBNP) ≥400 pg/mL or brain natriuretic peptide (BNP) ≥100 pg/mL.
•participants should be able to use smartphone well.

Exclusion Criteria

•Patients who have baseline systolic blood pressure \<90 mmHg or resting heart rate \<50 beats per minutes
•Patients who cannot use smartphone
•Patients who had cardiac implantable electronic device will be excluded

Outcomes

Primary Outcomes

HF symptom by questionnaire

Time Frame: 4 weeks

The degree of dyspnea will be evaluated by questionnaire. Range: 0(worst)-10(best)

HF symptom by application scores.

Time Frame: 4 weeks

the mean value of scores of dyspnea, fatigue, and ankle edema stored in app by participants will be evaluated. Range 0(no symptom) - 3(severe symptom)